Wen-Jie Sun, Xue-Dong An, Yue-Hong Zhang, Shan-Shan Tang, Yu-Ting Sun, Xiao-Min Kang, Lin-Lin Jiang, Xue-Fei Zhao, Qing Gao, Hang-Yu Ji, Feng-Mei Lian
{"title":"Autophagy-dependent ferroptosis may play a critical role in early stages of diabetic retinopathy.","authors":"Wen-Jie Sun, Xue-Dong An, Yue-Hong Zhang, Shan-Shan Tang, Yu-Ting Sun, Xiao-Min Kang, Lin-Lin Jiang, Xue-Fei Zhao, Qing Gao, Hang-Yu Ji, Feng-Mei Lian","doi":"10.4239/wjd.v15.i11.2189","DOIUrl":null,"url":null,"abstract":"<p><p>Diabetic retinopathy (DR), as one of the most common and significant microvascular complications of diabetes mellitus (DM), continues to elude effective targeted treatment for vision loss despite ongoing enrichment of the understanding of its pathogenic mechanisms from perspectives such as inflammation and oxidative stress. Recent studies have indicated that characteristic neuroglial degeneration induced by DM occurs before the onset of apparent microvascular lesions. In order to comprehensively grasp the early-stage pathological changes of DR, the retinal neurovascular unit (NVU) will become a crucial focal point for future research into the occurrence and progression of DR. Based on existing evidence, ferroptosis, a form of cell death regulated by processes like ferritinophagy and chaperone-mediated autophagy, mediates apoptosis in retinal NVU components, including pericytes and ganglion cells. Autophagy-dependent ferroptosis-related factors, including BECN1 and FABP4, may serve as both biomarkers for DR occurrence and development and potentially crucial targets for future effective DR treatments. The aforementioned findings present novel perspectives for comprehending the mechanisms underlying the early-stage pathological alterations in DR and open up innovative avenues for investigating supplementary therapeutic strategies.</p>","PeriodicalId":48607,"journal":{"name":"World Journal of Diabetes","volume":"15 11","pages":"2189-2202"},"PeriodicalIF":4.2000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11580571/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4239/wjd.v15.i11.2189","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic retinopathy (DR), as one of the most common and significant microvascular complications of diabetes mellitus (DM), continues to elude effective targeted treatment for vision loss despite ongoing enrichment of the understanding of its pathogenic mechanisms from perspectives such as inflammation and oxidative stress. Recent studies have indicated that characteristic neuroglial degeneration induced by DM occurs before the onset of apparent microvascular lesions. In order to comprehensively grasp the early-stage pathological changes of DR, the retinal neurovascular unit (NVU) will become a crucial focal point for future research into the occurrence and progression of DR. Based on existing evidence, ferroptosis, a form of cell death regulated by processes like ferritinophagy and chaperone-mediated autophagy, mediates apoptosis in retinal NVU components, including pericytes and ganglion cells. Autophagy-dependent ferroptosis-related factors, including BECN1 and FABP4, may serve as both biomarkers for DR occurrence and development and potentially crucial targets for future effective DR treatments. The aforementioned findings present novel perspectives for comprehending the mechanisms underlying the early-stage pathological alterations in DR and open up innovative avenues for investigating supplementary therapeutic strategies.
糖尿病视网膜病变(DR)是糖尿病(DM)最常见和最重要的微血管并发症之一,尽管人们从炎症和氧化应激等角度不断丰富对其致病机制的认识,但仍无法针对视力丧失采取有效的靶向治疗。最近的研究表明,糖尿病诱发的特征性神经胶质细胞变性发生在明显的微血管病变之前。为了全面掌握 DR 早期的病理变化,视网膜神经血管单元(NVU)将成为未来研究 DR 发生和发展的关键焦点。根据现有证据,铁蛋白吞噬是一种由铁蛋白吞噬和伴侣介导的自噬等过程调控的细胞死亡形式,它介导了视网膜神经血管单元成分(包括周细胞和神经节细胞)的凋亡。依赖自噬的铁蛋白吞噬相关因子(包括 BECN1 和 FABP4)既可作为 DR 发生和发展的生物标志物,也可能是未来有效治疗 DR 的关键靶点。上述发现为理解 DR 早期病理改变的机制提供了新的视角,并为研究辅助治疗策略开辟了创新的途径。
期刊介绍:
The WJD is a high-quality, peer reviewed, open-access journal. The primary task of WJD is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of diabetes. In order to promote productive academic communication, the peer review process for the WJD is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJD are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in diabetes. Scope: Diabetes Complications, Experimental Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes, Gestational, Diabetic Angiopathies, Diabetic Cardiomyopathies, Diabetic Coma, Diabetic Ketoacidosis, Diabetic Nephropathies, Diabetic Neuropathies, Donohue Syndrome, Fetal Macrosomia, and Prediabetic State.